Akesis Pharmaceuticals

• Home
• About Us
  • Fast Facts
  • Management
  • Board of Directors
  • Scientific Advisory Board
• Pipeline
  • The Diabetes Epidemic
  • Intellectual Property
• Investor Relations
  • Stock Information
  • Akesis Team
  • Press Releases
  • SEC Filings
• Contact Us
  • Contact Us
  • Legal Information

Jay Lichter, Ph.D.

Jay Lichter, Ph.D. is a seasoned biotechnology and pharmaceutical business executive with over 15 years of experience in management, scientific research and business development. Prior to joining Akesis, Dr. Lichter served as vice president of operations and business development of Sytera, Inc., an ophthalmology pharmaceutical company that merged in 2006 with Sirion Therapeutics, Inc. Prior to Sytera, he was executive vice president of business development for Sequenom Inc., a public biotechnology company. Previously, Dr. Lichter served as president and CEO of XenoPharm, Inc., a start-up company established with technology licensed to commercialize xenobiotic sensors. Earlier in his career, Dr. Lichter worked at both Pfizer, Inc. and Genset Corporation in various management capacities.

Dr. Lichter holds a Bachelor's degree and a Ph.D. in biochemistry from the University of Illinois. He completed Post-Doctoral Fellowships at Yale University and Du Pont Merck Pharmaceutical Company.